154 related articles for article (PubMed ID: 25075102)
21. Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.
Yamamoto N; Naraparaju VR
Immunol Cell Biol; 1998 Jun; 76(3):237-44. PubMed ID: 9682967
[TBL] [Abstract][Full Text] [Related]
22. Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.
Mohamad SB; Nagasawa H; Uto Y; Hori H
Comp Biochem Physiol A Mol Integr Physiol; 2002 May; 132(1):1-8. PubMed ID: 12062184
[TBL] [Abstract][Full Text] [Related]
23. Simple method for large-scale production of macrophage activating factor GcMAF.
Nabeshima Y; Abe C; Kawauchi T; Hiroi T; Uto Y; Nabeshima YI
Sci Rep; 2020 Nov; 10(1):19122. PubMed ID: 33154460
[TBL] [Abstract][Full Text] [Related]
24. Characteristic Morphological Changes and Rapid Actin Accumulation in Serum-MAF-treated Macrophages.
Kawakatsu K; Ishikawa M; Mashiba R; Tran NK; Akamatsu M; Nishikata T
Anticancer Res; 2019 Aug; 39(8):4533-4537. PubMed ID: 31366556
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Macrophage Activation Using γ-Globulin and Serum-derived Macrophage Activating Factor.
Akamatsu M; Mashiba R; Kawakatsu K; Ishikawa M; Nishikata T
Anticancer Res; 2020 Aug; 40(8):4707-4710. PubMed ID: 32727796
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.
Koga Y; Naraparaju VR; Yamamoto N
Proc Soc Exp Biol Med; 1999 Jan; 220(1):20-6. PubMed ID: 9893164
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF).
Yamamoto N; Ushijima N; Koga Y
J Med Virol; 2009 Jan; 81(1):16-26. PubMed ID: 19031451
[TBL] [Abstract][Full Text] [Related]
28. Antitumor effect of degalactosylated gc-globulin on orthotopic grafted lung cancer in mice.
Hirota K; Nakagawa Y; Takeuchi R; Uto Y; Hori H; Onizuka S; Terada H
Anticancer Res; 2013 Jul; 33(7):2911-5. PubMed ID: 23780979
[TBL] [Abstract][Full Text] [Related]
29. The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages.
Siniscalco D; Bradstreet JJ; Cirillo A; Antonucci N
J Neuroinflammation; 2014 Apr; 11():78. PubMed ID: 24739187
[TBL] [Abstract][Full Text] [Related]
30. Oleic Acid, deglycosylated vitamin D-binding protein, nitric oxide: a molecular triad made lethal to cancer.
Ruggiero M; Ward E; Smith R; Branca JJ; Noakes D; Morucci G; Taubmann M; Thyer L; Pacini S
Anticancer Res; 2014 Jul; 34(7):3569-78. PubMed ID: 24982371
[TBL] [Abstract][Full Text] [Related]
31. Effect of paricalcitol and GcMAF on angiogenesis and human peripheral blood mononuclear cell proliferation and signaling.
Pacini S; Morucci G; Punzi T; Gulisano M; Ruggiero M; Amato M; Aterini S
J Nephrol; 2012; 25(4):577-81. PubMed ID: 21956771
[TBL] [Abstract][Full Text] [Related]
32. Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis.
Kanda S; Mochizuki Y; Miyata Y; Kanetake H; Yamamoto N
J Natl Cancer Inst; 2002 Sep; 94(17):1311-9. PubMed ID: 12208896
[TBL] [Abstract][Full Text] [Related]
33. Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay.
Pacini S; Morucci G; Punzi T; Gulisano M; Ruggiero M
Cancer Immunol Immunother; 2011 Apr; 60(4):479-85. PubMed ID: 21170647
[TBL] [Abstract][Full Text] [Related]
34. Degalactosylated/Desialylated Bovine Colostrum Induces Macrophage Phagocytic Activity Independently of Inflammatory Cytokine Production.
Uto Y; Kawai T; Sasaki T; Hamada K; Yamada H; Kuchiike D; Kubo K; Inui T; Mette M; Tokunaga K; Hayakawa A; Go A; Oosaki T
Anticancer Res; 2015 Aug; 35(8):4487-92. PubMed ID: 26168491
[TBL] [Abstract][Full Text] [Related]
35. Development of an Evaluation Device for Phagocytic Activity of New Phagocytes Using Simple and pH-sensitive Particles that Do Not Require Pre-treatment.
Zhang R; Kobayashi Y; Kazumura K; Tsuchiya H; Morishita N; Inagawa H; Soma G
Anticancer Res; 2016 Jul; 36(7):3613-8. PubMed ID: 27354631
[TBL] [Abstract][Full Text] [Related]
36. Structural definition of a potent macrophage activating factor derived from vitamin D3-binding protein with adjuvant activity for antibody production.
Yamamoto N
Mol Immunol; 1996 Oct; 33(15):1157-64. PubMed ID: 9070663
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the Biological Properties of Blood Plasma Protein with GcMAF Functional Activity.
Dolgova EV; Kirikovich SS; Levites EV; Ruzanova VS; Proskurina AS; Ritter GS; Taranov OS; Varaksin NA; Ryabicheva TG; Leplina OY; Ostanin AA; Chernykh ER; Bogachev SS
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897653
[TBL] [Abstract][Full Text] [Related]
38. The effects of Phorbol 12-myristate 13-acetate concentration on the expression of miR-155 and miR-125b and their macrophage function-related genes in the U937 cell line.
Kuno S; Srinoun K; Penglong T
J Toxicol Sci; 2020; 45(12):751-761. PubMed ID: 33268675
[TBL] [Abstract][Full Text] [Related]
39. Association of the macrophage activating factor (MAF) precursor activity with polymorphism in vitamin D-binding protein.
Nagasawa H; Sasaki H; Uto Y; Kubo S; Hori H
Anticancer Res; 2004; 24(5C):3361-6. PubMed ID: 15515432
[TBL] [Abstract][Full Text] [Related]
40. Structural modification of serum vitamin D3-binding protein and immunosuppression in AIDS patients.
Yamamoto N; Naraparaju VR; Srinivasula SM
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1373-8. PubMed ID: 8573395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
